165 related articles for article (PubMed ID: 31471842)
1. The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma.
Beasley GM; Zager JS; Thompson JF
Ann Surg Oncol; 2020 Jan; 27(1):35-42. PubMed ID: 31471842
[TBL] [Abstract][Full Text] [Related]
2. Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?
Testori A; Intelisano A; Verrecchia F; Menicanti C; Tosti G; Grassi E; Pari C; Pennacchioli E
Dermatol Ther; 2012; 25(5):443-51. PubMed ID: 23046023
[TBL] [Abstract][Full Text] [Related]
3. Locoregional therapies in melanoma.
Abbott AM; Zager JS
Surg Clin North Am; 2014 Oct; 94(5):1003-15, viii. PubMed ID: 25245964
[TBL] [Abstract][Full Text] [Related]
4. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy for Cutaneous Melanoma.
Schuitevoerder D; Vining CC; Tseng J
Surg Oncol Clin N Am; 2020 Jul; 29(3):455-465. PubMed ID: 32482320
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of in-transit melanoma metastases.
Testori A; Ribero S; Bataille V
Eur J Surg Oncol; 2017 Mar; 43(3):544-560. PubMed ID: 27923593
[TBL] [Abstract][Full Text] [Related]
7. Regional therapies for in-transit disease.
Speicher PJ; Meriwether CH; Tyler DS
Surg Oncol Clin N Am; 2015 Apr; 24(2):309-22. PubMed ID: 25769714
[TBL] [Abstract][Full Text] [Related]
8. Commentary on pharmacotherapy of regional melanoma therapy.
Zager JS; Delman KA
Expert Opin Pharmacother; 2010 Jan; 11(1):1-3. PubMed ID: 20001424
[TBL] [Abstract][Full Text] [Related]
9. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.
Möller MG; Salwa S; Soden DM; O'Sullivan GC
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245
[TBL] [Abstract][Full Text] [Related]
10. Intralesional therapy for metastatic melanoma.
Sloot S; Rashid OM; Zager JS
Expert Opin Pharmacother; 2014 Dec; 15(18):2629-39. PubMed ID: 25381015
[TBL] [Abstract][Full Text] [Related]
11. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
12. Surgical issues in the management of melanoma.
Fraker DL
Curr Opin Oncol; 1997 Mar; 9(2):183-8. PubMed ID: 9161799
[TBL] [Abstract][Full Text] [Related]
13. Treatment of in-transit melanoma with intra-lesional interleukin-2: a systematic review.
Byers BA; Temple-Oberle CF; Hurdle V; McKinnon JG
J Surg Oncol; 2014 Nov; 110(6):770-5. PubMed ID: 24996052
[TBL] [Abstract][Full Text] [Related]
14. Isolation-perfusion: a valuable alternative in managing locally recurrent and in-transit melanoma.
Norvell ST; Bodurtha AJ
Can J Surg; 1983 Jan; 26(1):8. PubMed ID: 6821770
[No Abstract] [Full Text] [Related]
15. Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
Ocampo-Garza J; Gioia Di Chiacchio N; Haneke E; le Voci F; Paschoal FM
J Drugs Dermatol; 2017 Mar; 16(3):268-270. PubMed ID: 28301623
[TBL] [Abstract][Full Text] [Related]
16. Effective therapy: repeat limb perfusion for recurrent melanoma.
Krementz ET
J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
[No Abstract] [Full Text] [Related]
17. The use of isolated limb perfusion to manage recurrent malignant melanoma.
Ma D; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
19. Intralesional immunotherapy as a strategy to treat melanoma.
Nouri N; Garbe C
Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656
[TBL] [Abstract][Full Text] [Related]
20. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
Yao KA; Hsueh EC; Essner R; Foshag LJ; Wanek LA; Morton DL
Ann Surg; 2003 Nov; 238(5):743-7. PubMed ID: 14578738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
